期刊文献+

sCD40L对白血病K562细胞的影响及机制 被引量:1

Effect of Soluble CD40L on Leukemia K562 Cells and Its Mechanism
下载PDF
导出
摘要 目的:观察s CD40L对白血病K562细胞系生物学行为的影响并探讨其机制。方法:用不同浓度s CD40L处理K562细胞,通过检测细胞增殖抑制率筛选最佳s CD40L浓度;用最佳浓度s CD40L处理K562细胞,用流式细胞术检测K562细胞凋亡率、凋亡相关因子P53、BCL-2表达水平;ELISA法检测s CD40L处理后K562细胞Caspase8、Caspase 3表达水平。结果:最佳s CD40L实验浓度为4μg/ml;经s CD40L处理后K562细胞凋亡率明显增高,凋亡相关因子P53的表达明显上调,BCL-2的表达显著下调;经s CD40L处理的K562细胞上清液中Caspase 8、Caspase3水平明显增高。结论:4μg/ml s CD40L可显著抑制K562细胞增殖并可促进其凋亡,其机制可能与线粒体和P53途径通路有关。 Objective:To investigate the effect of sCD40 L on biological behavior of leukemia cell line K562 and the possible mechanism.Methods:The different concentration of sCD40 L was used to treat K562 cells,and the optimum concentration of sCD40 L was screened by detecting the proliferation inhibition rate of K562 cells.The optimum concentration of sCD40 L was used to treat K562 cells,the cell apoptosis rate and expression level of P53 and BCL-2were detected by flow cytometry and the expression levels of Caspase 8 and Caspase 3 were detected by ELISA.Results:The optimum concentration of sCD40 L was 4 μg/ml.After treated with sCD40 L,the cell apoptosis rate,the expression of apoptosis-related factor P53 and the expression of Caspase 8 and Caspase 3 were significantly up-regulated in K562 cells,but the expression of BCL-2 was significantly down-regulated.Conclusion:4 μg/ml sCD40 L can inhibit the cell proliferation and promote the apoptosis of K562 cells,its mechanism may be related with mitochondrial and P53 pathway.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2016年第4期1029-1033,共5页 Journal of Experimental Hematology
基金 贵州省科技厅社会发展攻关项目(黔科合SY字20143025)
关键词 SCD40L K562细胞 凋亡 sCD40L K562 cells apoptosis
  • 相关文献

参考文献7

  • 1Giovannini C,Minguzzi M,Baglioni M,et al.Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and mi R-221 axis in hepatocellular carcinoma. Oncotarget . 2014
  • 2Shin MK,Kim JW.Clinicopathologic and diagnostic significance of p53 protein expression in papillary thyroid carcinoma. Asian Pacific Journal of Cancer Prevention . 2014
  • 3王林,费嫦,黄峥兰,李会,刘张玲,冯文莉.重组腺病毒AdE-SH2-Caspase8对耐伊马替尼的K562/G01细胞凋亡的影响[J].中国实验血液学杂志,2015,23(4):976-981. 被引量:1
  • 4Zhang ZM,Yang XM,Zhang C,et al.Antitumor effects and mechanisms of dendritic cells stimulated by sCD40L on ovarian cancer cells in vitro. OncoTargets and Therapy . 2013
  • 5Solooki S,Khozaei A,Shamsdin SA,et al.s CD30 and s CD40L detection in patients with osteosarcoma,chondrosarcoma and Ewing sarcoma. Iran J Immunol . 2013
  • 6Shvetsov AV,Dyuzhikova NA,Savenko YN,et al.Effects of experimental coma on the expression of Bcl-2 protein and caspases 3and 9 in rat brain. Bulletin of Experimental Biology and Medicine . 2015
  • 7Adem J,Ropponen A,Eeva J,et al.Differential expression of Bcl-2 family proteins determines the sensitivity of human follicular lymphoma cells to dexamethasone-mediated and anti-BCRmediated apoptosis. Journal of Immunotherapy . 2016

二级参考文献12

  • 1Zhi Peng,Hong-Wei Luo,Ying Yuan,Jing Shi,Shi-Feng Huang,Chun-Li Li,Wei-Xi Cao,Zong-Gan Huang,Wen-Li Feng.Growth of chronic myeloid leukemia cells is inhibited by infection withAd-SH2-HA adenovirus that disrupts Grb2-Bcr-Abl complexes[J]. Oncology Reports . 2011 (5)
  • 2Kelly M Boatright,Martin Renatus,Fiona L Scott,Sabina Sperandio,Hwain Shin,Irene M Pedersen,Jean-Ehrland Ricci,Wade A Edris,Daniel P Sutherlin,Douglas R Green,Guy S Salvesen.A Unified Model for Apical Caspase Activation[J]. Molecular Cell . 2003 (2)
  • 3Martin R Sprick,Markus A Weigand,Eva Rieser,Charles T Rauch,Peter Juo,John Blenis,Peter H Krammer,Henning Walczak.FADD/MORT1 and Caspase-8 Are Recruited to TRAIL Receptors 1 and 2 and Are Essential for Apoptosis Mediated by TRAIL Receptor 2[J]. Immunity . 2000 (6)
  • 4Lugo TG,Pendergast AM,Muller AJ,et al.Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science . 1990
  • 5BJ Druker.Translation of the Philadelphia chromosome into therapy for CML. Blood . 2008
  • 6Quintás-Cardama Alfonso,Kantarjian Hagop,Cortes Jorge.Flying under the radar: the new wave of BCR-ABL inhibitors. Nature reviews. Drug discovery . 2007
  • 7Schiffer Charles A.BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. The New England Quarterly . 2007
  • 8Ann Marie Pendergast,Lawrence A. Quilliam,Larry D. Cripe,Craig H. Bassing,Zonghan Dai,Nanxin Li,Andreas Batzer,(...),Mikhail L. Gishizky.BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell . 1993
  • 9Puil L,Liu J,Gish G,et al.Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO Journal . 1994
  • 10Chu Su,Li Liang,Singh Harjeet,Bhatia Ravi.BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia. Cancer Research . 2007

共引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部